Scott Biller
InvestorVenture Partner at GV (Google Ventures)
Boston, Massachusetts
Writes $250K β $50M checks Β· typically $25M
About
Dr. Scott Biller is an Executive Venture Partner at GV with a deep R&D background, having served as Chief Scientific Officer of Agios Pharmaceuticals and held leadership roles at Novartis and Bristol-Myers Squibb. He advises and sits on the boards of several biotech companies including Foghorn, Remix, Rome, and OMass Therapeutics.
Invests in
BiotechMedical Devices
Experience
- OMass TherapeuticsBoard Membercurrent2022 β present
- GVExecutive Venture Partnercurrent2021 β presentCambridge, Massachusetts, United States
- ROME TherapeuticsBoard Membercurrent2021 β present
- Gate BioscienceBoard Observercurrent2021 β present
- Remix TherapeuticsBoard Membercurrent2020 β present
- Foghorn Therapeutics, IncBoard Membercurrent2020 β present
- VividionScientific Advisory Board member2019 β 2024
- Agios PharmaceuticalsScientific Advisory Board member2021 β 2023
- Agios PharmaceuticalsStrategic Advisor2020 β 2021
- Agios PharmaceuticalsChief Scientific Officer2010 β 2019
- Denali TherapeuticsScientific Advisory Board member2015 β 2023
- Novartis Institutes for BioMedical ResearchVice President, Global Discovery Chemistry2003 β 2010
- Bristol-Myers SquibbVice President, Pharmaceutical Candidate Optimization2001 β 2003
- Bristol Myers SquibbDirector, Executive Director, Discovery Chemistry1995 β 2001
- MITStudent1972 β 1976
Education
- Massachusetts Institute of TechnologyBS, Chemistry1972 β 1976
- Columbia UniversityPostdoc, Organic Chemistry1982 β 1983
- CaltechPhD, Organic Chemistry1976 β 1981
- Stuyvesant High SchoolHigh School Diploma, Chemistry1968 β 1972
Skills & more
Drug Discovery99Medicinal Chemistry56Drug Design40Organic Chemistry52Oncology34Chemistry99Drug Development99Lead Change24Lifesciences16Pharmacology27Cancer12Biochemistry27
+7 more
ADMEAssay DevelopmentNeuroscienceOrganic SynthesisLife SciencesPharmaceutical IndustryCROFrom Scott's professional profile.
Same school
Also attended Massachusetts Institute of Technology880
Fred WilsonCo-founder & Partner at Union Square VenturesAileen LeeFounder & Managing Partner of Cowboy VenturesHemant TanejaCEO & Managing Director of General CatalystBrad FeldCo-founder of Foundry and TechstarsMatt HuangCo-founder and Managing Partner at ParadigmDelian AsparouhovPartner at Founders Fund and co-founder of Varda
+ 874 more
Also attended Columbia University505
Ben HorowitzCo-founder & General Partner at Andreessen HorowitzDoug LeonePartner at Sequoia Capital; former Global Managing PartnerChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzGabriella GiglioHR & Executive Talent at General CatalystErica VanInvestment Director at Intel CapitalTom DanilekPartner, Rise of the Rest Real Estate at Revolution
+ 499 more
Also attended Caltech85
Shaun MaguirePartner at Sequoia CapitalSeth LieblichInvestment Team at 8VCMarkus EnzelbergerPartner at Versant VenturesWen HsiehFounding Managing Partner at Matter Venture PartnersHaomiao HuangFounding Partner at Matter Venture PartnersJordan CroomInvestor at Side Door Ventures
+ 79 more
Shared employers
Also worked at OMass Therapeutics2
Also worked at Remix Therapeutics3
Also worked at Foghorn Therapeutics, Inc2
Also worked at Novartis Institutes for BioMedical Research107
Rebecca JamesInvestor at Index VenturesFreya Svedberg-KeatingInvestor at MedicxiAndrea AmadorCompliance Manager at Inveready Technology Investment GroupAbbie CelnikerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock VenturesSteve TregayManaging General Partner at Mission Biocapital
+ 101 more
Investments
Board seats
Foghorn TherapeuticsOMASS TherapeuticsRemix TherapeuticsRome Therapeutics
Per the firm's website.
Colleagues at GV (Google Ventures)
Abe Rahey
Investor at GV (Google Ventures)
Abhishek Jain
Investor at GV (Google Ventures)
Andrew Patton
Advisor at GV (Google Ventures)
Andrew Wheeler
General Partner at GV (Google Ventures)
Anika Gupta
Investor at GV (Google Ventures)
Anika Gupta Vatsa
Principal at GV (Google Ventures)
Anthony Philippakis
Investor at GV (Google Ventures)
Ben Robbins
Investor at GV (Google Ventures)































